BSE filing, NSE: APARINDS. Summary written from the filing by ALFA Finder's alert engine.
Apar Industries Ltd: key numbers
- Share price
- ₹15,419.00
- Market cap
- ₹64,563 Cr
- Revenue (annual)
- ₹22,902 Cr
- Net profit (annual)
- ₹976.9 Cr
- P/E (TTM)
- 54.6×Sector 42.1×
- Promoter holding
- 55.42%-2.34% QoQ
- FII holding
- 12.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apar Industries Ltd
All →Apar Industries Employee Stock Options
Apar Industries' NCRC approved grant of 43,700 ESARs under its 2024 Plan at ₹15,153. Effective grant date is October 28, 2026.
Apar Industries Other Announcement
Apar Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Apar Industries Board Meeting Date
Apar Industries has scheduled its Board meeting for 29 October 2026 to approve Q2 and H1 FY27 results. The trading window closure runs until 31 October 2026.
Apar Industries Annual General Meeting
Apar Industries Ltd held its 37th AGM via video conferencing on September 21, 2026. The meeting covered ordinary business, including financial adoption and dividend declaration.
Apar Industries Other Announcement
Apar Industries' wholly owned subsidiary, APAR Industries Latam Ltda, has changed its name to APAR Brazil Ltda. This administrative update follows regulatory filing requirements.
Apar Industries Credit Rating
CARE upgraded Apar Industries' LT bank facility rating to CARE AA (Stable) from AA-. Short-term rating was reaffirmed at CARE A1+ following strengthening of capital structure post-QIP.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date